CRSP
Crispr Therapeutics AG
54.20$
-2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.16 | 2.03 | -4.51 | -1.75 | -2.01 | 1.00 | -3.61 | 6.70 | -6.38 | -3.29 | -1.69 | -3.84 | |
| 0.00 | 0.00 | 0.08 | 0.08 | 0.07 | 0.08 | 0.14 | 0.22 | 0.31 | 0.25 | 0.23 | 0.22 | |
| 0.02 | 0.13 | 0.88 | 0.47 | 0.73 | 0.77 | 1.00 | 1.27 | 1.26 | 1.02 | 1.03 | 0.81 | |
| 0.00 | 0.12 | -2.84 | 0.51 | 0.73 | 0.87 | 1.03 | 1.27 | 1.42 | – | – | – | |
| 0.05 | 2.78 | 0.15 | -0.63 | 0.22 | -0.85 | 0.51 | 0.33 | 0.26 | -2.44 | 1.85 | 0.80 | |
| 0.04 | 0.04 | 0.25 | 0.20 | 0.06 | 0.12 | 0.28 | 1.02 | 0.48 | 0.12 | 0.02 | 0.01 | |
| -0.04 | -0.04 | 2.60 | -0.21 | -0.06 | 0.02 | -8.21 | -12.88 | -3.33 | 4.73 | -3.32 | -0.35 | |
| – | – | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| 0.00 | 2.01 | 9.38 | 0.07 | 0.00 | 7.57 | 15.41 | 3.12 | 0.50 | – | – | 0.79 | |
| 1.31 | 1.31 | 2.86 | – | – | – | – | – | – | – | – | – | |
| 0.17 | 3.30 | 14.95 | 0.07 | 6.59 | 7.57 | 15.41 | 3.12 | 0.50 | 0.79 | 3.94 | 4.74 | |
| 0.02 | 5.29 | 13.02 | -1.89 | 4.52 | 8.59 | 3.59 | -3.05 | -9.21 | 2.24 | -1.08 | 0.55 | |
| -0.16 | 1.99 | -4.76 | -1.94 | -2.06 | 0.88 | -3.89 | 5.69 | -6.85 | -3.41 | -1.71 | -3.85 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.